Pfizer pledges $15 million to Clinton's Global Initiative for malaria

By Jennifer Chiou

New York, Sept. 20 - Pfizer, Inc. said that it committed $15 million to help close critical treatment gaps in malaria for patients in Senegal, Ghana and Kenya as part of a collaborative effort to address global health issues.

The funding will go through President Clinton's Global Initiative program.

The New York-based pharmaceutical company noted that malaria is Africa's leading cause of child mortality, with one out of every five children dying as a result of the disease.

"The malaria pandemic in Africa, responsible for 10% of the continent's overall disease burden, is a heartbreaking and frustrating challenge," chief medical officer Joseph Feczko said in a news release.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.